BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 9811471)

  • 21. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
    Ravitz MJ; Yan S; Herr KD; Wenner CE
    Cancer Res; 1995 Apr; 55(7):1413-6. PubMed ID: 7882344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
    Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
    Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a).
    Mitra J; Dai CY; Somasundaram K; El-Deiry WS; Satyamoorthy K; Herlyn M; Enders GH
    Mol Cell Biol; 1999 May; 19(5):3916-28. PubMed ID: 10207115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
    Li Y; Jenkins CW; Nichols MA; Xiong Y
    Oncogene; 1994 Aug; 9(8):2261-8. PubMed ID: 7913544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events.
    Wang H; Rubin M; Fenig E; DeBlasio A; Mendelsohn J; Yahalom J; Wieder R
    Cancer Res; 1997 May; 57(9):1750-7. PubMed ID: 9135019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.
    Goubin F; Ducommun B
    Oncogene; 1995 Jun; 10(12):2281-7. PubMed ID: 7784076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation.
    Poon RY; Toyoshima H; Hunter T
    Mol Biol Cell; 1995 Sep; 6(9):1197-213. PubMed ID: 8534916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage.
    Yuan ZM; Huang Y; Whang Y; Sawyers C; Weichselbaum R; Kharbanda S; Kufe D
    Nature; 1996 Jul; 382(6588):272-4. PubMed ID: 8717045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells.
    Seewaldt VL; Kim JH; Caldwell LE; Johnson BS; Swisshelm K; Collins SJ
    Cell Growth Differ; 1997 Jun; 8(6):631-41. PubMed ID: 9185997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cdk2 binding domain of p27Kip correlates with the inhibition of the kinase activity of cdk2/cyclin complexes.
    Kwon TK; Buchholz MA; Nordin AA
    Biochem Biophys Res Commun; 1996 Mar; 220(3):703-9. PubMed ID: 8607829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency.
    Lane HA; Beuvink I; Motoyama AB; Daly JM; Neve RM; Hynes NE
    Mol Cell Biol; 2000 May; 20(9):3210-23. PubMed ID: 10757805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
    Han H; Nomura T; Honjo T; Tsubata T
    Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.
    Planas-Silva MD; Weinberg RA
    Mol Cell Biol; 1997 Jul; 17(7):4059-69. PubMed ID: 9199341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression.
    Tam SW; Theodoras AM; Shay JW; Draetta GF; Pagano M
    Oncogene; 1994 Sep; 9(9):2663-74. PubMed ID: 8058330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
    Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA
    Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells.
    Tomida A; Suzuki H; Kim HD; Tsuruo T
    Oncogene; 1996 Dec; 13(12):2699-705. PubMed ID: 9000144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells.
    Hobeika AC; Subramaniam PS; Johnson HM
    Oncogene; 1997 Mar; 14(10):1165-70. PubMed ID: 9121765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridine-mediated growth arrest of human melanoma cells.
    Strasberg Rieber M; Welch DR; Miele ME; Rieber M
    Cell Growth Differ; 1996 Feb; 7(2):197-202. PubMed ID: 8822203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.
    Jones DL; Münger K
    J Virol; 1997 Apr; 71(4):2905-12. PubMed ID: 9060648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptosis and the cell cycle.
    Chiarugi V; Magnelli L; Cinelli M; Basi G
    Cell Mol Biol Res; 1994; 40(7-8):603-12. PubMed ID: 7787878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.